|
※サムネイル画像をクリックすると拡大画像が表示されます。
Immunofluorescence using Anti-HA Epitope Tag Antibody DyLight?800 Conjugated. Tirzepatide (TZP) differentially induces internalization of the GIP and GLP-1 receptors.(E?H) Studies using receptors containing an N-terminal HA-epitope tag and a C-terminal EGFP fusion are presented. (E) Changes in surface GIPR 60 minutes after treatment with ligand were measured by anti-HA immunofluorescence. Data are normalized to 1 μM GIP(1-42) values. For GIPR, tirzepatide induced internalization with an EC50?(SEM,?n) of 18.1 nM (5.7, 4), while GIP(1-42) displayed a potency of 18.2 nM (9.7, 4). (G) Representative confocal images of HA-GIPR-EGFP cells detecting EGFP fluorescence following treatment with vehicle, 100 nM GIP(1-42), or 100 nM tirzepatide. Figure 2. PMID: 32730231.
Immunofluorescence using Anti-HA Epitope Tag Antibody DyLight?800 Conjugated. Tirzepatide (TZP) differentially induces internalization of the GIP and GLP-1 receptors.(E?H) Studies using receptors containing an N-terminal HA-epitope tag and a C-terminal EGFP fusion are presented. (F) Changes in surface GLP-1R 30 minutes after treatment with ligand detected by anti-HA immunofluorescence. Data are normalized to 1 μM GLP-1(7-36) values. For GLP-1R, tirzepatide was partially efficacious at 43.6% (7.9, 3) with an EC50?of 101.9 nM (29.8, 3), while GLP-1(7-36) showed a potency of 22.2 nM (1.86, 3). (H) Representative confocal images of HA?GLP-1R?EGFP cells detecting EGFP fluorescence following treatment with vehicle, 100 nM GLP-1(7-36), or 100 nM tirzepatide. Scale bars: 20 μm. Figure 2. PMID: 32730231.
DyLight? dyes can be used for two-color Western Blot detection with low background and high signal.? Anti-tubulin was detected using a DyLight? 680 conjugate.? Anti-TNFa was detected using a DyLight? 800 conjugate. The image was captured using the OdysseyR Infrared Imaging System developed by LI-COR.
Properties of DyLight? Conjugates.
|
|
|
Immunofluorescence using Anti-HA Epitope Tag Antibody DyLight?800 Conjugated. Tirzepatide (TZP) differentially induces internalization of the GIP and GLP-1 receptors.(E?H) Studies using receptors containing an N-terminal HA-epitope tag and a C-terminal EGFP fusion are presented. (E) Changes in surface GIPR 60 minutes after treatment with ligand were measured by anti-HA immunofluorescence. Data are normalized to 1 μM GIP(1-42) values. For GIPR, tirzepatide induced internalization with an EC50?(SEM,?n) of 18.1 nM (5.7, 4), while GIP(1-42) displayed a potency of 18.2 nM (9.7, 4). (G) Representative confocal images of HA-GIPR-EGFP cells detecting EGFP fluorescence following treatment with vehicle, 100 nM GIP(1-42), or 100 nM tirzepatide. Figure 2. PMID: 32730231.
|
|
| 別品名 |
Rabbit Anti-HA Epitope Tag Antibody DyLight 800TM Conjugated, Rabbit Anti HA Epitope Tag Antibody DyLight 800TM Conjugated
|
| 免疫動物 |
Rabbit
|
| 抗原部位 |
a.a.114-122 (YPYDVPDYAG)
|
| 標識物 |
DyLightTM 800
|
| 精製度 |
Affinity Purified
|
| Tag情報 |
HA
|
| 参考文献 |
[Pub Med ID]33184279
|
| [注意事項] |
濃度はロットによって異なる可能性があります。メーカーDS及びCoAからご確認ください。
|
|
| メーカー |
品番 |
包装 |
|
RKL
|
600-445-384
|
100 UG
|
※表示価格について
| 当社在庫 |
なし
|
| 納期目安 |
約10日
|
| 法規制 |
毒
|
| 保存温度 |
4℃
|
|
※当社では商品情報の適切な管理に努めておりますが、表示される法規制情報は最新でない可能性があります。
また法規制情報の表示が無いものは、必ずしも法規制に非該当であることを示すものではありません。
商品のお届け前に最新の製品法規制情報をお求めの際はこちらへお問い合わせください。
|
※当社取り扱いの試薬・機器製品および受託サービス・創薬支援サービス(納品物、解析データ等)は、研究用としてのみ販売しております。
人や動物の医療用・臨床診断用・食品用としては、使用しないように、十分ご注意ください。
法規制欄に体外診断用医薬品と記載のものは除きます。
|
|
※リンク先での文献等のダウンロードに際しましては、掲載元の規約遵守をお願いします。
|